TOKYO - Takeda Pharmaceutical Co. Ltd. has entered into a basic research collaboration with NsGene AS for the development of an encapsulated cell therapy for Parkinson's disease, which will focus on the delivery of a neuro-regenerative growth factor to areas of the brain affected by the degenerative disorder.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?